An experimental drug created at the University of Notre Dame for diabetic foot ulcers, (R)-ND-336, also improved pressure ulcers, a new paper by Mayland Chang and Shahriar Mobashery has shown.

Read More

During fiscal year 2022, researchers at the University of Notre Dame received $244 million in research award funding, surpassing the previous record of $222.7 million set in fiscal year 2021.

Read More